GTC
CBAY

Ghost Tree Capital’s Cymabay Therapeutics CBAY Stock Holding History

Ghost Tree Capital’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-237,900
Closed -$3.55M – 83
2023
Q3 		$3.55M Buy
+237,900
New +$3.15M 1.17% 31

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Ghost Tree Capital's CBAY Position: Q1 2024 in Review

Ghost Tree Capital sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 90,000 shares — an estimated $2.13M sold.

Ghost Tree Capital first reported a position in CBAY in Q3 2015 and held it in 7 quarters. The position peaked at $9.96M in Q1 2019. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Ghost Tree Capital reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Ghost Tree Capital sold 90,000 Cymabay Therapeutics shares in Q1 2024, an estimated $2.13M.
  • Ghost Tree Capital first reported a position in Cymabay Therapeutics in Q3 2015 and held it in 7 quarters.
  • Ghost Tree Capital's Cymabay Therapeutics position peaked at $9.96M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Ghost Tree Capital's 13F filing for Q1 2024, filed 15 May 2024.